| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | 0.02 | 0.9 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.0037 | 0.9 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | 0.0038 | 0.9 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.0045 | 0.9 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | Ispinesib Mesylate | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |